SEARCH SITE

VIRGINIA LAW PORTAL

SEARCHABLE DATABASES

ACROSS SESSIONS

Developed and maintained by the Division of Legislative Automated Systems.

2016 SESSION

  • | print version

HB 337 Neurodegenerative diseases; informed consent to experimental treatment.

Introduced by: Brenda L. Pogge | all patrons    ...    notes | add to my profiles

SUMMARY AS INTRODUCED:

Informed consent to experimental treatment; neurodegenerative diseases. Provides that in the case of persons suffering from neurodegenerative diseases causing progressive deterioration of cognition for which there is no known cure, the implementation of experimental courses of therapeutic treatment, including non-pharmacological treatment, to which a legally authorized representative has given informed consent shall not constitute the use of force. This provision replaces a current provision that informed consent to experimental courses of treatment, without reference to non-pharmacological treatment, given by a legally authorized representative shall not constitute the use of force in cases of organic brain diseases causing progressive deterioration in which there is no known cure or medically accepted treatment to the disorder.


FULL TEXT

HISTORY